Arcturus therapeutics appoints moncef slaoui, ph.d., to board of directors

San diego--(business wire)---- $arct #clinicaltrial--arcturus therapeutics holdings inc. (the “company”, “arcturus”, nasdaq: arct), a global messenger rna medicines company focused on the development of infectious disease vaccines and medicines to treat unmet medical needs within liver and respiratory rare diseases, today announced the appointment of a new independent director, moncef slaoui, ph.d., to the company's board of directors. “dr. moncef slaoui brings extraordinary strategic expertise in pharmaceutical produc.
ARCT Ratings Summary
ARCT Quant Ranking